Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients

Table 1 The comparison of systemic immune inflammation index in patients with different clinicopathological features

Clinicopathological features	n	SII (%)	t	P value
Sex			-0.321	0.749
Male	40	519.29 ± 98.29
Female	28	526.84 ± 91.10
Age (yr)			-0.137	0.891
< 60	22	520.02 ± 94.50
≥ 60	46	523.54 ± 101.10
Ann Arbor stage			-2.377	0.020
I-II	41	501.22 ± 85.50
III-IV	27	554.56 ± 97.83
ECOG scores			-2.906	0.005
< 2	46	498.82 ± 95.30
≥ 2	22	571.70 ± 99.82
IPI scores			-1.378	0.173
0-1	36	506.60 ± 101.02
2-5	32	540.07 ± 98.82
Hans			-0.445	0.658
GCB	26	515.58 ± 100.43
Non GCB	42	526.62 ± 98.85
BCL2 expression			0.790	0.432
< 50%	40	530.03 ± 93.04
≥ 50%	28	511.50 ± 98.20
Ki-67			-0.402	0.689
< 70%	23	515.53 ± 99.40
≥ 70%	45	525.91 ± 101.43

SII: Systemic immune inflammation index; IPI: International prognostic index; ECOG: Eastern Cooperative Oncology Group; GCB: Germinal center B-cell.